-
41
Novel combination therapy for platinum-eligible patients with locally advanced or metastatic urothelial carcinoma: a systematic review and network meta-analysis
Published 2025-02-01“…Cancer Immunology, Immunotherapy…”
Get full text
Article -
42
Correction: Pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail in pretreated patients with persistent, recurrent, or metastatic cervical or endometrial carcino...
Published 2024-12-01“…Cancer Immunology, Immunotherapy…”
Get full text
Article -
43
Nicotine promotes M2 macrophage polarization through α5-nAChR/SOX2/CSF-1 axis in lung adenocarcinoma
Published 2024-11-01“…Cancer Immunology, Immunotherapy…”
Get full text
Article -
44
Correction: Risk factors indicating immune-related adverse events with combination chemotherapy with immune checkpoint inhibitors and platinum agents in patients with non-small cel...
Published 2024-12-01“…Cancer Immunology, Immunotherapy…”
Get full text
Article -
45
HDAC1-3 inhibition triggers NEDD4-mediated CCR2 downregulation and attenuates immunosuppression in myeloid-derived suppressor cells
Published 2025-02-01“…Cancer Immunology, Immunotherapy…”
Get full text
Article -
46
New insights into the immunomodulatory potential of sialic acid on monocyte-derived dendritic cells
Published 2024-11-01“…Cancer Immunology, Immunotherapy…”
Get full text
Article -
47
A comprehensive analysis of molecular characteristics of hot and cold tumor of gastric cancer
Published 2025-02-01“…Cancer Immunology, Immunotherapy…”
Get full text
Article -
48
Elevated SAMD3 expression in T cells predicts improved survival in pancreatic ductal adenocarcinoma patients
Published 2025-02-01“…Cancer Immunology, Immunotherapy…”
Get full text
Article -
49
KMO-driven metabolic reconfiguration and its impact on immune cell infiltration in nasopharyngeal carcinoma: a new avenue for immunotherapy
Published 2025-02-01“…Cancer Immunology, Immunotherapy…”
Get full text
Article -
50
Differences in immune-related toxicity between PD-1 and PD-L1 inhibitors: a retrospective cohort study in patients with advanced cancer
Published 2024-11-01“…Cancer Immunology, Immunotherapy…”
Get full text
Article -
51
Interdependence of coagulation with immunotherapy and BRAF/MEK inhibitor therapy: results from a prospective study
Published 2024-11-01“…Cancer Immunology, Immunotherapy…”
Get full text
Article -
52
Artificial neural network systems to predict the response to sintilimab in squamous-cell non-small-cell lung cancer based on data of ORIENT-3 study
Published 2024-12-01“…Cancer Immunology, Immunotherapy…”
Get full text
Article -
53
SUMO modified ETV1 promotes M2-polarized tumor-associated macrophage infiltration and cancer progression by facilitating CCL2 transcription in esophageal squamous cell carcinoma ce...
Published 2025-02-01“…Cancer Immunology, Immunotherapy…”
Get full text
Article -
54
The performance status gap in immunotherapy for frail patients with advanced non-small cell lung cancer
Published 2024-07-01“…Cancer Immunology, Immunotherapy…”
Get full text
Article -
55
Antitumor effects of natural killer cells derived from gene-engineered human-induced pluripotent stem cells on hepatocellular carcinoma
Published 2025-02-01“…Cancer Immunology, Immunotherapy…”
Get full text
Article -
56
Periodontitis promotes tumor growth and immune evasion via PD-1/PD-L1
Published 2024-11-01“…Cancer Immunology, Immunotherapy…”
Get full text
Article -
57
Pre-injection of exosomes can significantly suppress ovarian cancer growth by activating the immune system in mice
Published 2025-02-01“…Cancer Immunology, Immunotherapy…”
Get full text
Article -
58
Targeting OAS3 for reversing M2d infiltration and restoring anti-tumor immunity in pancreatic cancer
Published 2024-12-01“…Cancer Immunology, Immunotherapy…”
Get full text
Article -
59
Pre-immunotherapy alters stereotactic ablative radiotherapy-induced systemic T cell responses in early-stage NSCLC
Published 2025-02-01“…Cancer Immunology, Immunotherapy…”
Get full text
Article -
60
Dendritic cell maturation is induced by p53-armed oncolytic adenovirus via tumor-derived exosomes enhancing systemic antitumor immunity
Published 2024-11-01“…Cancer Immunology, Immunotherapy…”
Get full text
Article